The Motley Fool

Your Weekly German Stock Review (10/27/2014 – 10/31/2014)

In this weekly feature, we’ll give a brief snapshot of the big stories and big stock moves that shaped the markets.

Figures in this article reflect prices as of market close on 10/30/2014

3 Aktien, die jetzt von der Digitalisierung der Welt profitieren Das Coronavirus verändert nachhaltig die Welt, in der wir leben. Die Digitalisierung der Welt ist nicht mehr aufzuhalten und erfährt aktuelle eine massive Beschleunigung. The Motely Fool hat jetzt 3 Unternehmen identifiziert, die von diesem Mega-Trend in 2020 und den kommenden Jahren stark profitieren werden. Für uns Kerninvestments der neuen, digitalen Welt 2.0. Fordere die kostenlose Analyse jetzt hier ab..

The major indices

After a slight drop over the weekend that put the index back under 9,000 at Monday’s open, the DAX rose for the week, closing above 9,100 on Thursday, continuing what is starting to seem like a steady climb towards the 9,600s of a month ago. The MDAX (the next 50 largest German stocks, excluding tech), the TecDAX (the 30 largest tech stocks), and the HDAX (all stocks on the DAX, MDAX, and TecDAX), were all up, although all three showed better performance than the DAX in the latter part of the week.

One Step Forward, Two Steps Back

Last week, all eyes were on the banks, as the European Central Bank’s stress test results were due out on Sunday. A collective sigh of relief could be heard as all major banks – including Deutsche Bank (ETR: DBK) (FRA: DBK) and Commerzbank (ETR: CBK) (FRA: CBK) – passed the tests. The markets posted big gains in response.

However, the exuberance was short-lived. Two hours later, the Ifo Institute, based in Munich, released its German Business Climate Index, which fell for the sixth consecutive month in October, signaling, in the words of Ifo President Hans-Werner Sinn, that “economic prospects have worsened even further” in Germany. This triggered a selling spree that nearly erased all of the morning’s gains.

Adding to the bad news, the Association of German Chambers of Commerce and Industry predicted the German economy would only expand by 1.3 percent this year and just 0.8 percent in 2015. The markets shook off the bad news, though, and still managed to post modest gains over the course of the week, aided by a Thursday report from the Federal Labor Office that German unemployment fell unexpectedly in October.

For Halloween, This Week’s Tricks and Treats

TREAT: STRATEC Biomedical AG (ETR: SBS) (FRA: SBS) had an excellent week, in which it was a top gainer in the HDAX on Monday (up 1.37%, 3rd highest gain), Wednesday (up 3.59%, 5th highest gain), and Thursday (up another 3.43%, 6th highest gain). All this apparently because of last Wednesday’s report that net income, sales, and EPS for the first nine months of this year all handily beat last year. Analyst reaction was mixed, however, with DZ Bank recommending selling, Deutsche Bank moving it to “hold,” and Kepler Cheuvreux moving it to “Buy.” Since the announcement, STRATEC’s stock has risen more than 14%.

TRICK: Bavarian lender Münchener Hypothekenbank (STR: MTN-HPF) was the only German bank to fail the recent ECB stress tests. The bank has said they have already raised more capital to cover any potential shortfall.

TRICK: Lufthansa (ETR: LHA) (FRA: LHA) lowered its 2015 guidance for the second time this year, blaming a sputtering global economy. Its stock price sputtered in response, dropping more than 7% on Thursday.

TREAT: Bayer (ETR: BAYN) (FRA: BAYN) reported third-quarter earnings slightly ahead of expectations, largely due to strong pesticide sales. Analyst Bernstein raised the stock’s rating to “Outperform” from “Market perform” and the stock rose almost 2.5% on Thursday, up more than 4% for the week.

May your portfolio be full of treats, and no tricks: happy Halloween!

Buffetts Mega-Milliardenwetten zum Nachahmen

Bis zu 130 Mrd. US-Dollar investiert Investorenlegende Warren Buffett in nur ein einziges Unternehmen. Das zeugt von riesigem Vertrauen in das Zukunftspotential.

Buffett hat so einige Mega-Milliardeninvestments in seinem Portfolio. Wir haben sie näher analysiert, und angesehen, inwieweit sie sich zum Nachahmen eignen.

Du kannst alle Details und unsere Tipps dazu erfahren, indem du unseren kostenlosen Spezialreport hier anforderst.

John Bromels does not own any of the stocks mentioned in this article. The Motley Fool does not own any stocks mentioned in this article.

 

Diese Aktien empfehlen wir jetzt zum Kauf

Die Post-Corona Ära: Die neue Normalität +++ Worauf du dich jetzt einstellen solltest +++ Wo die Redaktion des Stock Advisor Deutschland jetzt die größten Kaufchancen sieht+++Die 3 besten Kennzahlen für deinen Sicherheits-Depotcheck+++

Welche Aktien haben jetzt die besten Chancen , in der Post-Corona Ära zu bestehen und davon zu profitieren?

Wir sind fest davon überzeugt, dass Investoren langfristig belohnt werden, wenn sie jetzt bewährte Foolishe Kriterien beachten.

Teste jetzt 30 Tage lang Stock Advisor Deutschland und erhalten sofortigen Zugriff auf alle aktuellen Kaufempfehlungen und Inhalte!

Klick hier für alle Details!